Lion's Mane vs Ginkgo Biloba: Neurogenesis or Cerebral Blood Flow?
By Peter Orpen � Updated 27 March 2026 � Reviewed by the Teelixir Research Team
Evidence Snapshot � What the Research Shows
Lion's Mane and Ginkgo biloba are frequently grouped together as "natural nootropics," but this comparison obscures a fundamental difference: they target entirely separate aspects of brain biology. Understanding that distinction � honestly � is the most useful thing this article can do for you.
Lion's Mane (Hericium erinaceus) stimulates the production of nerve growth factor (NGF), promoting the growth and repair of nerve tissue. Ginkgo biloba enhances cerebral blood flow through vasodilation, delivering more oxygen and nutrients to brain cells that already exist. One builds new neural connections. The other nourishes existing ones.
This is not a case where one supplement is simply "better." They address different problems through different mechanisms. What follows is an honest comparison grounded in the actual evidence � including where that evidence is weak, inconsistent, or genuinely uncertain.
How Lion's Mane Supports the Brain: Neurogenesis and NGF
MechanismThe key bioactive compounds in Lion's Mane are hericenones (from the fruiting body) and erinacines (from the mycelium). Both classes of compound cross the blood-brain barrier and stimulate the synthesis of NGF � a protein responsible for the growth, maintenance, and survival of neurons. This is not a sedative or stimulant effect; it is a structural intervention that promotes neuroplasticity over time.
A 2025 systematic review (PMID: 40959699) examining all published preliminary research found that Lion's Mane enhanced pro-BDNF and BDNF production, promoted hippocampal neurogenesis, and improved cognitive function across multiple trials. In the RCT evidence base, a 2023 double-blind, parallel-groups study (n=41 healthy adults aged 18�45) found that a single dose of 1.8 g Hericium erinaceus produced significantly faster Stroop task performance at 60 minutes post-dose (PMID: 38004235). Cognitive speed � not just memory � appears to be an acute effect of Lion's Mane, not only a long-term one.
The landmark Mori et al. (2009) trial (PMID: 18844328) demonstrated significant cognitive improvements in older adults with mild cognitive impairment (MCI) following 16 weeks of Lion's Mane supplementation, with scores declining after cessation � suggesting the effect is active and ongoing rather than a one-time correction.
How Ginkgo Biloba Supports the Brain: Blood Flow and Antioxidant Activity
MechanismGinkgo biloba's primary active compounds are flavonoid glycosides (antioxidants) and terpene lactones � specifically ginkgolides A, B, C, and bilobalide. Ginkgolides inhibit platelet-activating factor (PAF), which improves blood flow through vasodilation. Bilobalide has neuroprotective effects and may reduce ischaemic damage in neural tissue.
The result is improved cerebral circulation: more oxygen and glucose reaching brain cells, and better clearance of metabolic waste. This makes Ginkgo particularly relevant where vascular function is the limiting factor � in ageing brains with reduced blood flow, or in conditions like vascular dementia.
Ginkgo's evidence base is genuinely large � over 4,000 published studies and 82 RCTs assessed in the 2026 Cochrane systematic review (PMID: 41641880, 10,613 participants). This dwarfs the Lion's Mane evidence base in sheer volume.
In people with mild cognitive impairment (MCI): Ginkgo "probably has little or no effect at six months on global status, cognition, or ADLs" (moderate-certainty evidence). In people with existing dementia: "there may be small to moderate benefits at six months for global status, cognition, and ADLs" (low-certainty evidence). For healthy adults with cognitive complaints: evidence is "very low certainty." The updated review analysed 82 RCTs with 10,613 participants � this is the most comprehensive evaluation of Ginkgo evidence ever conducted.
A separate 2024 review of EGb761 trials for mild-to-moderate dementia (PMID: 39792490) � covering 18 years of trials � concluded bluntly: improvements in MMSE and SKT scores "did not reach the threshold for clinically significant enhancement," and the paper questioned whether continuing this line of research is warranted. For healthy adults without cognitive impairment, a 2026 network meta-analysis (PMID: 41678913, 29 RCTs, 2,107 participants) found that Ginkgo at both low and high doses was significantly outperformed by Bacopa monnieri for working memory and short-term memory outcomes.
Head-to-Head Comparison
| Feature | Lion's Mane | Ginkgo Biloba |
|---|---|---|
| Classification | Functional mushroom (adaptogen/nootropic) | Herbal medicine (circulatory/neuroprotective) |
| Primary mechanism | NGF + BDNF stimulation, neuroplasticity | Cerebral vasodilation, PAF inhibition, antioxidant |
| How it supports cognition | Promotes nerve growth, synaptic repair, new connections | Increases oxygen and nutrient delivery to existing brain cells |
| Human RCTs | 7 RCTs (small, mostly positive) | 82 RCTs, 10,613 participants (mixed results) |
| Cochrane review | None | Yes (2026) � "probably little or no effect" for MCI; "may have small benefits" for dementia |
| Best evidence population | Healthy adults, mild cognitive impairment | Existing dementia (vascular or Alzheimer's type) |
| Time to effect | Acute (1 dose); chronic benefit builds over 2�4 weeks | Typically 4�6 weeks for cognitive effects |
| Active compounds | Hericenones, erinacines, beta-glucans | Flavonoid glycosides, ginkgolides A/B/C, bilobalide |
| Drug interactions | No significant known interactions | Anticoagulants (warfarin), antidepressants (SSRIs/MAOIs), anticonvulsants, NSAIDs |
| Key safety concern | Rare mild GI effects; avoid if mushroom allergy | Bleeding risk (PAF inhibition), headache, seizure risk at high doses (theoretical) |
| Standard dose | 500�3,000 mg/day of fruiting body extract | 120�240 mg/day EGb761 standardised extract |
| Standardisation | Beta-glucan content (look for 20%+) | 24% flavone glycosides, 6% terpene lactones (EGb761) |
The Evidence Gap: Why Ginkgo Has More Studies But Not Clearer Results
Ginkgo biloba's research history spans several decades, largely driven by interest in dementia � a condition for which there are few effective treatments. This created enormous research activity. But scale has not translated to consistency. The 2026 Cochrane review (PMID: 41641880) � the gold standard in evidence synthesis � found that for MCI, the effect is "probably little or no." For dementia, benefits are "small to moderate" but low-certainty and statistically heterogeneous (I� = 88�96%), meaning results vary substantially across trials.
The GEM trial (n=3,069, PMID: 19017911) � the largest primary prevention trial of Ginkgo ever conducted � found no benefit for preventing dementia or slowing cognitive decline in older adults. This is the trial that matters most for the question "should I take Ginkgo to protect my brain as I age," and the answer it gives is: probably not.
Lion's Mane, by contrast, has a small but more consistent positive signal in its trial record. The 2025 systematic review (PMID: 40959699) found MMSE scores in the intervention group increased by a weighted mean of 1.17 points across trials where dementia-related measures were used. The mechanism � NGF and BDNF stimulation with neuroplastic effects � is well-characterised at the cellular level. The preliminary research is still early, but it points in a consistent direction.
Neither supplement has undergone the kind of large, long-duration, multi-centre RCT that would provide high-certainty evidence for cognitive enhancement in healthy adults. Both are working with incomplete evidence bases in that population.
Drug Interactions: A Practical Consideration That Matters
This section deserves more emphasis than it typically receives in supplement comparison articles.
Ginkgo biloba's PAF inhibitory activity gives it genuine anticoagulant properties. This is not theoretical � it translates to a clinically meaningful increased bleeding risk when combined with:
- Warfarin and other anticoagulants � risk of serious bleeding events
- NSAIDs (aspirin, ibuprofen, naproxen) � additive antiplatelet effects
- SSRIs and MAOIs � increased risk of serotonin syndrome (theoretical) and bleeding
- Anticonvulsants � Ginkgo may lower seizure threshold
- Diabetes medications � may alter insulin response
Anyone on prescription medication should consult their healthcare practitioner before using Ginkgo.
Lion's Mane has no known significant drug interactions documented in the clinical literature. This is not absence of caution � it means the interaction profile is substantially cleaner, which matters for older adults who are more likely to be taking multiple medications and are also the population most commonly considering cognitive support supplements.
Can You Take Lion's Mane and Ginkgo Together?
The mechanisms are complementary: Lion's Mane builds and repairs nerve tissue at the structural level; Ginkgo increases the blood supply nourishing that tissue. No known direct interaction exists between the two compounds. If you are not taking any medication that interacts with Ginkgo, combining both is physiologically rational.
However, "complementary mechanisms" does not automatically translate to "double the benefit." No trial has tested this combination directly. The practical consideration remains: if you are taking any blood-thinning or psychoactive medication, the Ginkgo component requires medical supervision. This restriction does not apply to Lion's Mane.
Lion's Mane: Best For
Neuroplasticity and nerve repair, long-term brain maintenance, cognitive speed and focus, people who want minimal drug interaction risk, healthy adults of any age building cognitive resilience.
Ginkgo: Best For
Supporting cerebral circulation, particularly where age-related vascular changes are a concern. More studied in populations with existing cognitive impairment. Not appropriate if on anticoagulants or multiple medications without medical advice.
Which Should You Choose?
- Choose Lion's Mane if: You want neuroplasticity support through NGF/BDNF stimulation, you value a cleaner drug interaction profile, or you are a healthy adult wanting proactive long-term cognitive support.
- Choose Ginkgo if: Cerebral blood flow is the primary concern (e.g., age-related circulatory changes), you are not taking any medications that interact with anticoagulants, and you are comfortable with a more complex evidence landscape.
- Consider both if: You want to support both nerve growth and cerebral circulation � the mechanisms are non-overlapping and complementary. Speak with your practitioner if on any medications, specifically regarding the Ginkgo component.
- Important: Neither supplement replaces medical assessment for cognitive decline. If you are concerned about memory or cognition, speak with your GP as a first step.
Teelixir Lion's Mane: Dual Extraction Captures Both Active Compound Classes
Not all Lion's Mane supplements are equivalent. Hericenones are alcohol-soluble; beta-glucans and erinacine-type compounds are water-soluble. A hot-water-only extraction misses the hericenones entirely � the compounds most associated with NGF stimulation in the fruiting body.
Teelixir's Lion's Mane extract uses a 10:1 dual extraction process (hot water and ethanol extraction) from 100% fruiting body, Di Tao sourced from Zhejiang Province. The certificate of analysis confirms 31.7% beta-glucan content. Avoid products derived from mycelium grown on grain � these are primarily starch, not mushroom, and do not deliver meaningful concentrations of the key bioactive compounds.
Frequently Asked Questions
Is Ginkgo biloba more proven than Lion's Mane?
Ginkgo has been studied far more extensively � 4,000+ studies and 82 RCTs assessed in the 2026 Cochrane review (PMID: 41641880). However, volume does not equal consistent positive outcomes. For mild cognitive impairment, the Cochrane review found Ginkgo "probably has little or no effect." For healthy adults, the evidence for cognitive enhancement is modest. Lion's Mane has fewer trials but a more consistent positive signal, particularly for neuroplasticity and NGF-mediated effects.
Can I take Lion's Mane with blood thinners?
Lion's Mane has no known significant interactions with anticoagulant medications. This is a meaningful practical advantage over Ginkgo biloba, which inhibits platelet-activating factor and carries a clinically documented increased bleeding risk when combined with warfarin, aspirin, or other blood-thinning agents. Always consult your healthcare practitioner before combining any supplement with prescription medication.
Which is better for preventing dementia?
Neither has been proven to prevent dementia. The largest Ginkgo prevention trial (GEM study, n=3,069, PMID: 19017911) found no benefit for preventing dementia in older adults. Lion's Mane shows promising early data through its NGF and BDNF-stimulating mechanisms, but no large prevention trial has been conducted. The 2025 systematic review on Lion's Mane (PMID: 40959699) reported consistent improvements in cognitive measures across trials, with the research focus primarily on MCI populations. Neither supplement should be used as a substitute for medical care if you have concerns about cognitive decline.
Does Ginkgo work faster than Lion's Mane?
Ginkgo's vasodilatory effects on cerebral blood flow can occur within hours, but measurable cognitive improvements in trials typically require 4�6 weeks of consistent use. Interestingly, a 2023 Lion's Mane RCT (PMID: 38004235) demonstrated significantly faster Stroop task performance after a single dose at 60 minutes � suggesting acute cognitive effects from Lion's Mane that are not commonly highlighted. Long-term neuroplastic benefits from Lion's Mane build over weeks of consistent use.
Is Lion's Mane suitable for younger adults, not just older people?
Yes. The Docherty et al. (2023) RCT (PMID: 38004235) specifically recruited healthy adults aged 18�45 � a younger demographic than most cognitive supplement trials � and found benefits in cognitive speed and a trend toward reduced stress with chronic use. The neuroplasticity mechanisms of Lion's Mane (NGF, BDNF stimulation) are relevant across the adult lifespan, not only in ageing populations.
What is the difference between Lion's Mane fruiting body and mycelium?
The fruiting body (the mushroom itself) contains hericenones � the alcohol-soluble compounds linked to NGF stimulation. The mycelium (the root-like network) contains erinacines. Products grown on grain substrates often contain high proportions of starch from the growing medium rather than mushroom bioactives. Teelixir uses 100% fruiting body with dual extraction to capture both water-soluble and alcohol-soluble compounds. Always check for a beta-glucan content figure on the product's certificate of analysis � starch-heavy products will not provide this information.
Continue reading: Complete Lion's Mane benefits guide � Lion's Mane and Alzheimer's research � Lion's Mane dosage guide
This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease or health condition. Teelixir products are food supplements, not medicines. Always consult your qualified healthcare practitioner before starting any new supplement, particularly if you are pregnant, breastfeeding, taking prescription medication, or have a diagnosed medical condition.
Continue Your Research
- Lion's Mane Benefits: What 571 Studies Actually Show
- Lion's Mane vs Ashwagandha: The NGF-Cortisol Effect Explained
- Lion's Mane vs Cordyceps: Brain Power or Physical Energy?
- Lion's Mane vs Reishi: Which Medicinal Mushroom Is Right for You?
- Lion's Mane vs Chaga: Cognitive Support or Antioxidant Power?
- Lion’s Mane vs Turkey Tail: Brain Support or Immune Defence?
- Lion's Mane vs Bacopa Monnieri: Two Nootropics, Two Pathways
- Lion's Mane Side Effects: Safety Profile Review